Skip to main content
RUBICON RESEARCH LIMITED logo

RUBICON RESEARCH LIMITED — Investor Relations & Filings

Ticker · RUBICON ISIN · INE506V01022 LEI · 335800GME6PCQIKP8T34 BSE.NS Manufacturing
Open in API
Filings indexed 116 across all filing types
Latest filing 2026-02-03 Regulatory Filings
Country IN India
Listing BSE.NS RUBICON

About RUBICON RESEARCH LIMITED

https://www.rubicon.co.in/

Rubicon Research Limited is a specialty organization focused on formulation development and the commercialization of value-added products. The company leverages proprietary drug delivery technology platforms to develop complex oral solids, liquids, topicals, and sterile dosage forms. Its core business activities encompass contract research and manufacturing services alongside the development of a diverse portfolio of Abbreviated New Drug Applications. The firm operates advanced research and development centers and manufacturing facilities that comply with stringent international regulatory standards. Rubicon Research emphasizes innovation in life cycle management and the enhancement of existing molecules to improve patient compliance and therapeutic outcomes. Its operations provide end-to-end solutions from initial concept and formulation design to commercial-scale production, serving global markets with a focus on high-quality, technology-driven solutions.

Recent filings

Filing Released Lang Actions
Outcome of the Board Meeting held on Tuesday, February 03, 2026
Regulatory Filings
2026-02-03 English
Change in Auditors
Board/Management Information Classification · 90% confidence The document is a disclosure under Regulation 30 of SEBI Listing Regulations reporting the outcome of a Board Meeting, specifically announcing the appointment and resignation of directors and other board-level decisions. This is an announcement of changes in the company's board and senior management rather than a full financial report or other category. Therefore it falls under Board/Management Information (MANG).
2026-02-03 English
Change in Director(s)
Board/Management Information Classification · 95% confidence The document is a SEBI Regulation 30 disclosure reporting the outcome of a Board meeting, including appointment and resignation of directors and other board-level actions. It is an announcement of changes in the company’s board and senior management. Therefore, it fits the Board/Management Information category.
2026-02-03 English
Outcome of Board Meeting
Board/Management Information Classification · 95% confidence The document is a disclosure under SEBI Listing Regulations regarding the outcome of a Board of Directors meeting. It primarily announces the appointment and resignation of directors and secretarial auditor, and in-principle merger approval. This is an announcement of changes in board composition and management, matching the ‘Board/Management Information’ category (MANG).
2026-02-03 English
Please find attached Monitoring Agency Report for the quarter ended December 31, 2025.
Capital/Financing Update Classification · 95% confidence The document is titled 'Monitoring Agency Report for the quarter ended December 31, 2025' related to the utilization of proceeds from an Initial Public Offering (IPO). It references SEBI regulations specifically related to monitoring the use of IPO proceeds, includes detailed financial data on the deployment and utilization of funds, and is issued by a monitoring agency with oversight from the company's audit committee and board. The document is comprehensive (15,000 characters) and contains substantive financial and compliance information about the IPO proceeds usage for a specific quarter. This fits the definition of a Capital/Financing Update (CAP), as it provides updates on the company's capital raised through IPO and the monitoring of those funds. It is not an announcement of a report, nor a full annual or interim financial report, nor a regulatory filing or certification. Therefore, the appropriate classification is CAP with high confidence.
2026-02-03 English
Financial Results for Quarter ended December 31, 2025.
Regulatory Filings
2026-02-03 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.